Alan

Co founder and owner of Volttage and VolttageBuzz. Geek. Transplant into Dallas.

CDC Encourages Testing Among Latino Men

In an effort to promote HIV/AIDS testing in minority communities, the Centers for Disease Control and Prevention (CDC) in Atlanta has launched a national campaign to encourage HIV/AIDS testing among gay and bisexual Latino men. The campaign, Reasons/Razones, asks the simple question, “What is your reason for getting an HIV test?” Images of family, friends and partners highlight the advertisements that will appear in print, online and in broadcasts across the country in the next several months. “Latinos are one… Read more

Peter Staley: Progress on marriage has meant a setback in the fight against AIDS

In an Op/Ed piece in the Washington Post, activist Peter Staley calls for the LGBT community to recommit itself to fighting HIV and AIDS: …in our exaltation over wedded bliss, we are forgetting another kind of “til death do us part”: the bonds that tie us together as a group, across social strata, race and generations — the same bonds that helped us fight AIDS…. …HIV remains the largest health issue facing the gay community. From 2008 to 2010, according to the… Read more

NYT: Aging with HIV

On Saturday, The New York Times published a a piece about the growing number of middle age and older New Yorkers who are HIV positive, and the challenges they face. Not long ago, it would have seemed unthinkable: H.I.V. is becoming a disease of the middle-aged. Nearly half of New Yorkers with H.I.V. are now 50 or older, ages many never dreamed of reaching… …Their stories have largely moved out of the spotlight, as the disease seemed to yield to the miracle… Read more

Seriously Kansas? Quarantining People With HIV?

A Kansas bill designed to help protect paramedics and firefighters appears to have been hijacked to potentially legalize quarantining people with HIV/AIDS. The bill would allow firefighters and paramedics exposed to bodily fluids during the course of their duties to require the person they were treating or helping to take a blood test to rule out HIV infection. Currently this can only happen via a court order which takes time. However, because the bill dealt specifically with HIV, lawmakers on… Read more

USPSTF Wants Routine HIV Screening

Routine HIV screening – a proposed recommendation by the U.S. Preventive Services Task Force — is likely to remove important barriers that leave about 25% of HIV-positive people unaware they have the virus. In two separate Perspective articles, published online in the New England Journal of Medicine, experts argue that the proposed recommendation has the potential for some far-reaching consequences, including getting more people into care, improving their health, and slowing the rate of transmission of HIV. The task force is suggesting… Read more

NAPWA declares bankruptcy

The Washington Blade reports that the National Association of People with AIDS is closing its doors. With creditors owed more than $750,000, the National Association of People with AIDS filed for Chapter 7 bankruptcy and announced it is going out of business 30 years after it was founded in 1983. One source familiar with NAPWA and some of its board members said the bankruptcy filing follows reports late last year that as much as $700,000 in NAPWA funds was either missing… Read more

Jack featured in “M” Magazine for the Modern Man

Volttage co-owner and creator Jack Mackenroth was featured on this month’s eddition of South African M: For The Modern Man. Check out the interview, starting on Page 29. [issuu layout=http%3A%2F%2Fskin.issuu.com%2Fv%2Fdark%2Flayout.xml showflipbtn=true documentid=130216073731-a71f98cf8ef249a1a5ec65170eb5e740 docname=m3digimag username=mmagazineza loadinginfotext=M%20Magazine%20-%20M3 showhtmllink=false tag=bisexual width=600 height=424 unit=px]

Dolutegravir To Get FDA Priority Review

ViiV Healthcare Ltd., a joint venture of GlaxoSmithKline Plc and two other drugmakers, said its experimental HIV medicine dolutegravir will get a speedier review by the U.S. Food and Drug Administration. A regulatory decision is scheduled for Aug. 17 after Viiv submitted an application on Dec. 17. The FDA gave dolutegravir priority review status, which is granted to drugs that have the potential to offer significant improvement over existing therapies or where no adequate treatment exists, the company said. The… Read more

Back to Top